Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration

Stroke

Volumn 42, Issue 11, 2011, Pages 3150-3155

  Kimura, Kazumi ^a   Sakamoto, Yuki ^a   Aoki, Junya ^a   Iguchi, Yasuyuki ^a   Shibazaki, Kensaku ^a   Inoue, Takashi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

MRA, T2recanalization; susceptibility vessel sign; tissue type plasminogen activator

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ACUTE DISEASE; AGED; ARTERY DISEASE; ARTICLE; BLOOD VESSEL PARAMETERS; BRAIN ISCHEMIA; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; M1 OCCLUSION; M1 SUSCEPTIBILITY VESSEL SIGN; M2 OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECANALIZATION; SENSITIVITY AND SPECIFICITY; STROKE;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80054998733     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.623207     Document Type: Article

References (23)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
2. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
3. Delgado-Mederos R, Rovira A, Alvarez-Sabin J, Ribo M, Munuera J, Rubiera M, et al. Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke. Stroke. 2007;38:955-960. (Pubitemid 46568458)
4. Kim YS, Garami Z, Mikulik R, Molina CA, Alexandrov AV. Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke. 2005;36:869-871.
5. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke. 2004;35:151-156. (Pubitemid 38057610)
6. Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005;36:1452-1456. (Pubitemid 40967511)
7. Zangerle A, Kiechl S, Spiegel M, Furtner M, Knoflach M, Werner P, et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology. 2007;68:39-44. (Pubitemid 46058549)
8. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-mHz transcranial Doppler monitoring. Stroke. 2000;31:610-614. (Pubitemid 30131644)
9. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, et al. Combined intravenous and intra-arterial rtPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) bridging trial. Stroke. 1999;30:2598-2605.
10. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432-1438. (Pubitemid 40967507)
11. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol. 2006;27:1177-1182. (Pubitemid 44897621)
12. Kimura K, Iguchi Y, Shibazaki K, Aoki J, Watanabe M, Matsumoto N, et al. Early stroke treatment with IV tPA associated with early recanalization. J Neurol Sci. 2010;295:53-57.
13. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV tPA in acute ischemic stroke. J Neurol Sci. 2008;267:57-61. (Pubitemid 351248907)
14. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke. 2004;35:486-490. (Pubitemid 38174434)
15. Tandberg Askevold E, Naess H, Thomassen L. Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2007;16:21-24. (Pubitemid 46073787)
16. Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2-weighted gradient echo imaging for identification of stroke subtypes. Stroke. 2005;36:2379-2383. (Pubitemid 41566962)
17. Kimura K, Iguchi Y, Shibazaki K, Watanabe M, Iwanaga T, Aoki J. M1 susceptibility vessel sign on T2 as a strong predictor for no early recanalization after IV tPA in acute ischemic stroke. Stroke. 2009;40:3130-3132.
18. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007;38:948-954. (Pubitemid 46568457)
19. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37: 1810-1815. (Pubitemid 44297734)
20. Albanese MA, Clarke WR, Adams HP Jr, Woolson RF. Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke. 1994;25:1746-1751. (Pubitemid 24274965)
21. Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallee PC, et al. Comparison of intravenous alteplase with a combined intravenous- endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): A prospective cohort study. Lancet Neurol. 2009;8:802-809.
22. Furst G, Saleh A, Wenserski F, Malms J, Cohnen M, Aulich A, Neumann-Haefelin T, Schroeter M, Steinmetz H, Sitzer M. Reliability and validity of noninvasive imaging of internal carotid artery pseudoocclusion. Stroke. 1999;30:1444-1449. (Pubitemid 29296075)
23. Teitelbaum GP, Ortega HV, Vinitski S, Clark RA, Watanabe AT, Matsumoto AH, et al. Optimization of gradient-echo imaging parameters for intracaval filters and trapped thromboemboli. Radiology. 1990;174:1013-1019. (Pubitemid 20089734)